Vitamin D and cancer: does it really matter?

Area of Science:

• Oncology
• Endocrinology
• Nutritional Science

Background:

• Vitamin D is crucial for calcium and phosphate homeostasis and bone health.
• Calcitriol (1,25-dihydroxy-vitamin D3) acts as a steroid hormone with extraskeletal functions.
• Preclinical research indicates vitamin D may influence cancer pathways by promoting differentiation and inhibiting proliferation.

Purpose of the Study:

• To provide a background for evidence-based decisions on vitamin D prescription for cancer prevention.
• To evaluate the role of vitamin D in improving oncological outcomes.

Main Methods:

• Review of existing literature including meta-analyses and randomized clinical trials.
• Analysis of preclinical studies on vitamin D's cellular mechanisms.
• Examination of epidemiological data on vitamin D and cancer.

Main Results:

• A 2014 review suggested a beneficial role for vitamin D in cancer development.
• A Cochrane meta-analysis of 18 trials found no difference in cancer incidence with vitamin D supplementation in healthy populations.
• A phase III trial in the New England Journal of Medicine found no protective effect against adenoma development.

Conclusions:

• Clinical evidence on vitamin D supplementation for cancer prevention and treatment remains inconsistent.
• While vitamin D has demonstrated anticancer properties in preclinical models, its clinical efficacy is not yet established.
• Further research is needed to clarify the role of vitamin D in cancer prevention and patient outcomes.